Article
Rapid identification of compound mutations in patients with Philadelphia-positive leukaemias by long-range next generation sequencing.
European journal of cancer (Oxford, England : 1990) - 1 Mar 2014
Kastner R, Zopf A, Preuner S, Pröll J, Niklas N, Foskett P, Valent P, Lion T, Gabriel C
Abstract excerpt
An emerging problem in patients with Philadelphia (Ph)-positive leukaemias is the occurrence of cells with multiple mutations in the BCR-ABL1 tyrosine kinase domain (TKD) associated with high resistance to different tyrosine kinase inhibitors. Rapid and sensitive detection of leukaemic subclones carrying such changes, referred to as compound mutations, is therefore of increasing clinical relevance. However,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
